Cargando…
Role of Clofazimine in Treatment of Mycobacterium avium Complex
Background: Non-tuberculous mycobacteria (NTM), specifically Mycobacterium avium complex (MAC), is an increasingly prevalent cause of pulmonary dysfunction. Clofazimine has been shown to be effective for the treatment of M. avium complex, but there were no published large-scale analyses comparing cl...
Autores principales: | Nasiri, Mohammad Javad, Calcagno, Tess, Hosseini, Sareh Sadat, Hematian, Ali, Nojookambari, Neda Yousefi, Karimi-Yazdi, Mohammadmahdi, Mirsaeidi, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099105/ https://www.ncbi.nlm.nih.gov/pubmed/33968952 http://dx.doi.org/10.3389/fmed.2021.638306 |
Ejemplares similares
-
Novel Administration of Clofazimine for the Treatment of Mycobacterium avium Infection
por: Valinetz, Ethan, et al.
Publicado: (2020) -
Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series
por: Tahvildari, Azin, et al.
Publicado: (2020) -
Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021) -
Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease
por: Kim, Bo-Guen, et al.
Publicado: (2020) -
COVID-19 and cause of pregnancy loss during the pandemic: A systematic review
por: Kazemi, Seyyedeh Neda, et al.
Publicado: (2021)